Mascarenhas, J., Kuykendall, A., Bradley, T., Scott, B., Yimer, H., Yang, Y., Huang, F., Wan, Y., Navada, S., Ho, J., Berry, T., Otoukesh, S. (2025). Improvemf: Phase 1b trial of imetelstat plus ruxolitinib in patients with intermediate-2 or high-risk myelofibrosis. Blood. https://doi.org/10.1182/blood-2025-2052